Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5176 AL 5190

Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis

Wang J, Yu JT, Wang HF, Meng XF, Wang C, Tan CC, Tan L.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):101-9. doi: 10.1136/jnnp-2014-308112. Epub 2014 May 29.

Neuropsychiatric symptoms of dementia: are pharmacological treatments effective and safe?

Ford AH.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):4. doi: 10.1136/jnnp-2014-308420. Epub 2014 May 29.

[Alzheimer's Disease Cooperative Study (ADCS)]

Mori H, Ikeuchi T.

Brain Nerve. 2014 Jun;66(6):691-8.

An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease

Shah RC, Matthews DC, Andrews RD, Capuano AW, Fleischman DA, VanderLugt JT, Colca JR.

Curr Alzheimer Res. 2014;11(6):564-73. doi: 10.2174/1567205011666140616113406.

Rivastigmine transdermal patch and physical exercises for Alzheimer's disease: a randomized clinical trial

Aguiar P, Monteiro L, Feres A, Gomes I, Melo A.

Curr Alzheimer Res. 2014;11(6):532-7. doi: 10.2174/1567205011666140618102224.

Cholinesterase inhibitors and add-on nutritional supplements in Alzheimer's disease: a systematic review of randomized controlled trials

Rijpma A, Meulenbroek O, Olde Rikkert MG.

Ageing Res Rev. 2014 Jul;16:105-12. doi: 10.1016/j.arr.2014.06.002. Epub 2014 Jun 27.

"The Castle of Remembrance": New insights from a cognitive training programme for autobiographical memory in Alzheimer's disease

Lalanne J, Gallarda T, Piolino P.

Neuropsychol Rehabil. 2015;25(2):254-82. doi: 10.1080/09602011.2014.949276. Epub 2014 Aug 14.

Is cognitive training an effective treatment for preclinical and early Alzheimer's disease?

Gates NJ, Sachdev P.

J Alzheimers Dis. 2014;42 Suppl 4:S551-9. doi: 10.3233/JAD-141302.

Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease

Arai H, Ichimiya Y, Shibata N, Nakajima T, Sudoh S, Tokuda T, Sujaku T, Yokokawa S, Hoshii N, Noguchi H, Bille A.

Psychogeriatrics. 2014 Sep;14(3):165-74. doi: 10.1111/psyg.12055. Epub 2014 Sep 3.

The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: preliminary findings on recruitment and caregiving burden in the baseline population

Chiatti C, Rimland JM, Bonfranceschi F, Masera F, Bustacchini S, Cassetta L; Fabrizia Lattanzio; UP-TECH research group.

Aging Ment Health. 2015;19(6):517-25. doi: 10.1080/13607863.2014.954526. Epub 2014 Sep 4.

Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease

Wattmo C, Londos E, Minthon L.

BMC Neurol. 2014 Sep 10;14:173. doi: 10.1186/s12883-014-0173-4.

Compassion fatigue in adult daughter caregivers of a parent with dementia

Day JR, Anderson RA, Davis LL.

Issues Ment Health Nurs. 2014 Oct;35(10):796-804. doi: 10.3109/01612840.2014.917133.

Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial

Wilkinson D, Windfeld K, Colding-Jørgensen E.

Lancet Neurol. 2014 Nov;13(11):1092-1099. doi: 10.1016/S1474-4422(14)70198-X. Epub 2014 Oct 5.

Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial)

Yu F, Bronas UG, Konety S, Nelson NW, Dysken M, Jack C Jr, Wyman JF, Vock D, Smith G.

Trials. 2014 Oct 11;15:394. doi: 10.1186/1745-6215-15-394.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias